Having problems viewing this e-mail ?
November 2012
Registration opens for the PGIP quarterly
meeting in Lansing
Online registration is now open for the PGIP December 2012 Quarterly
Meeting at Lansing Community College-West campus. On-site attendance is limited to medical and executive leadership at the morning meeting with live streaming offered to an unlimited number of additional participants. Specific interest group breakout sessions will also be accessible via live streaming while others will provide remote access via the AT&T conference call or webinar numbers. BCBSM’s Value-Based Contracting Strategy
will be discussed at December PGIP
Quarterly Meeting
Join us from 11:15 a.m. to 12:15 p.m., Dec. 7, 2012, at the PGIP
Quarterly Meeting in Lansing, Michigan, for an informational, open discussion breakout session on BCBSM’s value-based hospital contracting strategy. The session will take place in the Main Room immediately following the morning meeting. get the full benefit of PGIP Matters.
PGIP grows with four new POs in 2013
PGIP will invite four new physician organizations to join PGIP for the
2013 program year. As contracted entities, the four POs are invited to participate in activities such as the PGIP initiatives. PGIP PA and Self-Assessment Data Tools to
Replace the SRD in 2013
As presented at the September PGIP Quarterly meeting, Value
Partnerships has developed a new Web-based toolset to replace the SRD beginning summer 2013. The PGIP Practitioner Alignment tool will be used to maintain your PO physician list, and the Self-Assessment Data tool will be used to report Practice Unit PCMH/Technical August 2012 Progress Report – Summary
Report and Informational Webinar
Twice a year, PGIP conducts surveys of all the physician organizations[11/28/2012 12:32:05 PM] to obtain important information on administrative function, capabilities and performance on initiatives. The summary findings from the August 2012 survey titled, August 2012 Progress Report will be available on Nov.19, 2012. The survey is an evaluation of PO initiative engagement during a seven-month period, from February 2012 to August 2012).
These findings are also a key component in initiative evaluation by our PGIP Grants Update
In the November 2010 PGIP Matters, we reported on several newly
awarded grants aimed at evaluating various aspects of the BCBSM Value Partnerships programs. At the time, researchers from the University of Michigan and Michigan State University were awarded more than $3.5 million to study and evaluate the programs and determine their relevance on a national scale. PGIP Journey available on the PO
Collaborative site
Seven years since the inception of the program, PGIP continues to lead
the way in health care transformation through the development of innovative programs and initiatives that are improving the quality and affordability of care throughout the state. To chronicle the PGIP journey and to provide a glimpse of the “past, present, and future” of the program, Value Partnerships created a document titled, The PGIP Journey: A Path to Healthcare Transformation. Generics for Singulair® and Singulair
Chewable® now available.
An important generic opportunity in Asthma and Allergy

Aug. 9 marked the official launch of Montelukast Sodium Tablets (10mg) and Montelukast Sodium Chewable Tablets in 4mg and 5mg.
Montelukast, the FDA-approved generic for the brand name product Singulair® represents an important addition to the growing list of major generic drug products launched in 2012. Singulair® as a branded product was responsible for national sales of $4 billion dollars per year.
In 2011, it represented the sixth highest drug expenditure for Blue Cross Blue Shield of Michigan. Multiple manufacturers were available at the time of launch, driving the price to nominal levels. You have received this e-mail because you have registered with Blue Cross Blue Shield of Michigan. To ensure that you continue to receive these e-mails, please add to your e-mail address book or safe-sender list. This e-mail was sent to:
This e-mail was sent by: Blue Cross Blue Shield of Michigan 600 E. Lafayette, Detroit, MI, 48226, USA For questions on PGIP Matters articles, contact Elizabeth Chouinard at.[11/28/2012 12:32:05 PM][11/28/2012 12:32:05 PM]


Arzerra - ct-8366

COMMISSION DE LA TRANSPARENCE ARZERRA 100 mg, solution à diluer pour perfusion B/3 (CIP 577 117-9) B/10 (CIP 577 118-5) GLAXOSMITHKLINE Ofatumumab Code ATC: L01XC10 Liste I Médicament orphelin (7/11/2008) Médicament réservé à l’usage hospitalier. Prescription réservée aux spécialistes en oncologie ou hématologie ou aux médecins compétents en cancérologie. Médic

Método de indução

O termo «indução» tem origem na Filosofia. A entrada do Dicionário de Fi- losofia de Simon Blackburn que lhe diz respeito começa do seguinte modo: Indução Termo usado sobretudo para designar qualquer processo de raciocí- nio que nos conduza de premissas empíricas a conclusões empíricas, que,apesar de apoiadas pelas premissas, não são dedutivamente deriváveisdelas. Assim, in

Copyright © 2014 Articles Finder